You are here

Researchers and Physicians

Leaders Make Collaboration Focus of Cancer Moonshot Summit

As a part of Vice President Joe Biden’s Cancer Moonshot Summit in Washington, DC last month, leaders from North Carolina’s three comprehensive cancer centers gathered at the University of North Carolina at Chapel Hill to convene their own regional summit. “The goal of the ‘moonshot’ is to propel us...

Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People

Shelley Hwang, MD , chief of breast surgery at the Duke Cancer Institute, has been named one of TIME’s 100 most influential people for 2016 as a pioneer in her field. One of the world’s foremost experts in early-stage breast cancers, Hwang has become an international leader calling for research to...

A Small Price to Pay

Kristin Schroeder, MD, MPH, remembers the dad that called to tell her he had found a way to pay for the medicine to treat his son’s lymphoma; he had just sold his cow. He said he would come the next day to get the chemo at Bugando Medical Centre in Mwanza, Tanzania. “I said, ‘oh my goodness!’ A cow...

Paul Modrich Shares Nobel Prize in Chemistry

Duke Cancer Institute member Paul Modrich, PhD, was awarded the 2015 Nobel Prize in Chemistry. Modrich is also a James B. Duke professor in the Department of Biochemistry at Duke University School of Medicine and a Howard Hughes Medical Institute investigator. He shares the prize with Aziz Sancar,...

Fluorescence Lights Up Hidden Cancer

Surgery is a crucial weapon against cancer. But cancer can evade it. A surgeon may think all the tumor has been removed, only to find out from pathology reports that some was left behind. That can mean a second surgery for the patient. Or, if microscopic cancer cells aren’t found by pathologists,...

The Double Agent Drug

Ines Batinic-Haberle and colleagues developed BMX-001 based on a discovery in a Duke basic research lab. The drug will first be tested in patients with brain cancer and head and neck cancer in clinical trials at Duke in 2016. Duke Cancer Institute member Ines Batinic-Haberle, PhD, holds a vial of...

A New Generation of Therapies for Prostate Cancer

Dan George, M.D., is a medical oncologist and director of Duke Cancer Institute Genitourinary Oncology. He and his colleagues at Duke are continually working to offer better treatment options to men with prostate cancer. What is the outlook for men with prostate cancer? Today we are able to help...

Hit Me With Your Best Shot

Duke Cancer Institute physician Brent Hanks, MD, PhD, is studying patient tumors to reveal the genetic changes that happen when melanomas win a battle and become resistant to immunotherapy treatments. In the last couple of years, patients with advanced melanoma have gained an ally in their fight...

The Answer on the Other End of the Leash

Will Edward, DVM, MD, works to find better treatments for a cancer called sarcoma. It makes no difference to him that half of his patients walk on four legs and bark at the doorbell. Eward, an assistant professor of orthopaedics, treats dogs at Triangle Veterinary Referral Hospital, as well as...